Responses
Correction
Correction: Incidence rates of immune-related adverse events and their correlation with response in advanced solid tumours treated with NIVO or NIVO+IPI: a systematic review and meta-analysis
Compose a Response to This Article
Other responses
No responses have been published for this article.